Add to My Stocks
HealthSouth Revenue Chart
$44.81 $0.9 (2.05%) HLS stock closing price Sep 25, 2017 (Closing)
The latest 2017-Q2 HealthSouth revenue is 981.3M. Compare HealthSouth revenue chart with DAVITA INC revenue, ENVISION HLTHCR revenue.
HLS Revenue Chart
You can do annual as well as quarterly comparisons of HealthSouth Corp net sales with its competitor companies like DAVITA INC, ENVISION HLTHCR. Over the 5 year period HealthSouth revenue in 2016 was highest at 3.65B. In the latest quarter, HLS revenue 2017-Q2 has changed from 974.8M to 981.3M implying an increase of 0.67%.
HealthSouth Quarterly Revenue
* Past 5 years Range
|Max HLS Revenue||$981.3M||Jun, 2017|
|Min HLS Revenue||$537M||Sep, 2012|
HealthSouth Annual Revenue
* Past 5 years Range
|Max HLS Revenue||$3.65B||Dec, 2016|
|Min HLS Revenue||$2.13B||Dec, 2012|
HealthSouth Annual Revenue VS Peers
|DAVITA INC Revenue||$14.75B||$13.78B||$12.8B||$11.76B||$8.19B|
|ENVISION HLTHCR Revenue||$3.7B||$2.57B||$1.62B||$1.08B||$928.5M|
|Select Medical Revenue||$4.29B||$3.74B||$3.07B||$2.98B||$2.95B|
|USMD Holdings Revenue||----||$325.15M||$294.76M||$234.72M||$105.7M|
|First Choice Revenue||$29.46M||$19.51M||$8.1M||$6.14M||----|
HealthSouth Stock Articles
Revenue or net sales is the total amount of money that a company brings in through its various business activities before any costs or expenses are deducted. Revenue is also known as the topline or net sales or gross income. Revenue is for a specific period of time and appears as the "top line" in an income statement. By subtracting the costs or expenses from HealthSouth topline, we arrive at the bottom line for the company. Growing revenues over a period of time generally indicate that the company is in good health, however other factors need to be factored. Revenue can be calculated in two ways based on the type of accounting followed: accrual accounting or cashflow accounting. It is useful to compare HealthSouth revenue with peers DAVITA INC topline, ENVISION HLTHCR topline, Select Medical topline; to see how the company is doing with respect to its peers.